From MDEX web-site
The MDEX Consortium has recently been succesful in obtaing a prestigious joint award from the Department of Health and the Wellcome Trust for a period of 36 months totalling up to nearly £2.5 Million to Dr Matthew Wood and Professor Francesco Muntoni for the study 'Advanced antisense oligonucleotide technology for exon skipping in Duchenne muscular dystropy'. The award will facilitate research in the laboratories of Dr Mattew Wood (Oxford), Professor Francesco Muntoni/Dr Jenny Morgan (UCL/ICH), Professors Kate Bushby/Volker Straub (Newcastle), Professor George Dickson (Royal Holloway), Professor Dominic Wells (Royal Veterinary) and Dr Mike Gait (Cambridge). The award includes funding for a clinical trial in year 2 onward in London and Newcastle. More details on the award will be available in our News section in due course.
PRAYERS (and fingers crossed) that this along with Prof Steve Wilton work will enable exon skipping to all the mutations.
Replies to This Discussion
-
Permalink Reply by cheryl cliff on
-
Can't help but love this news, thanks Raktim for finding & sharing the article. It does further my belief that treatments will not be available in the US until after they are available everywhere else. Plus, there is a recent announcement that FDA intends to go after pharma CEO's criminally, should they buck the system. Might scare off the ones we need the most!
Still stocking up on sweaters to take to the UK.
-
Permalink Reply by RAKTIM SINGH on
-
You are welcome Cheryl. As such it is good that various groups are putting money into Advanced antisense oligonucleotide technology for exon skipping ( and to various researchers who are working for DMD). I hope and PRAY ( fingers crossed) that all this will help all DMD kids. I am sure all these cures will reach all countries ASAP.
-
-
Some more funds and hopefully more lights for National Children's Hospital for muscular dystrophy research/work.
http://www.newswise.com/articles/7-million-nih-grant-designates-nat...
Newswise — A $7 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children’s Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children’s Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.
-
-
Music to my ears!
RAKTIM SINGH said:Some more funds and hopefully more lights for National Children's Hospital for muscular dystrophy research/work.
http://www.newswise.com/articles/7-million-nih-grant-designates-nat...
Newswise — A $7 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children’s Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children’s Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
